NewsRx

Search our medical news database

Cancer Gene Therapy

Immunotoxin DNA Immunization Stimulates Strong Anti-Tumor Activity

Published in Gene Therapy Weekly, March 9th, 1998

DNA immunization with the immunotoxin mesothelin combines selective cytotoxicity, with high activity, stability and effective tumor killing.

Mesothelin is a 40-kDa glycosylphosphatidylinositol-linked glycoprotein that is present on the surface of several types of human cancers including ovarian carcinoma and rare mesotheliomas. In normal tissues, it is present only on mesothelial cells. Mesothelin is membrane-bound and is not detected in the blood of cancer patients nor shed in the medium from cultured cells.

Partha S. Chowdhury and colleagues from the U.S. National Cancer Institute, Maryland, suggested that the presence of mesothelin on the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook